Denali Advisors LLC increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 14.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,400 shares of the company’s stock after buying an additional 300 shares during the quarter. Denali Advisors LLC’s holdings in HCA Healthcare were worth $800,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Parkside Financial Bank & Trust grew its position in shares of HCA Healthcare by 8.2% during the 4th quarter. Parkside Financial Bank & Trust now owns 461 shares of the company’s stock worth $125,000 after buying an additional 35 shares during the period. FinTrust Capital Advisors LLC boosted its stake in HCA Healthcare by 26.7% during the 4th quarter. FinTrust Capital Advisors LLC now owns 166 shares of the company’s stock worth $45,000 after acquiring an additional 35 shares during the last quarter. Ballentine Partners LLC boosted its stake in HCA Healthcare by 1.0% during the 1st quarter. Ballentine Partners LLC now owns 3,879 shares of the company’s stock worth $1,294,000 after acquiring an additional 38 shares during the last quarter. Wedmont Private Capital lifted its stake in HCA Healthcare by 1.6% in the fourth quarter. Wedmont Private Capital now owns 2,527 shares of the company’s stock valued at $711,000 after buying an additional 39 shares in the last quarter. Finally, Valley Wealth Managers Inc. lifted its stake in HCA Healthcare by 4.1% in the fourth quarter. Valley Wealth Managers Inc. now owns 981 shares of the company’s stock valued at $266,000 after buying an additional 39 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at HCA Healthcare
In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the sale, the senior vice president now owns 22,365 shares in the company, valued at $6,977,880. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, SVP Kathryn A. Torres sold 973 shares of HCA Healthcare stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the transaction, the senior vice president now owns 22,365 shares in the company, valued at $6,977,880. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Jeffrey E. Cohen sold 1,650 shares of HCA Healthcare stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $313.00, for a total transaction of $516,450.00. Following the transaction, the senior vice president now owns 5,185 shares in the company, valued at approximately $1,622,905. The disclosure for this sale can be found here. Insiders have sold 12,397 shares of company stock worth $3,921,929 over the last quarter. Corporate insiders own 1.70% of the company’s stock.
Wall Street Analyst Weigh In
Get Our Latest Stock Analysis on HCA
HCA Healthcare Stock Up 2.1 %
Shares of HCA opened at $326.31 on Thursday. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $344.20. The firm’s 50 day moving average is $326.06 and its 200-day moving average is $318.07. The stock has a market capitalization of $85.46 billion, a PE ratio of 16.27, a P/E/G ratio of 1.48 and a beta of 1.68. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26.
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. The business had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The firm’s quarterly revenue was up 11.2% compared to the same quarter last year. During the same period last year, the firm posted $4.93 earnings per share. Equities research analysts forecast that HCA Healthcare, Inc. will post 20.92 EPS for the current year.
HCA Healthcare Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, June 28th. Shareholders of record on Friday, June 14th were given a $0.66 dividend. The ex-dividend date of this dividend was Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a yield of 0.81%. HCA Healthcare’s dividend payout ratio is currently 13.16%.
HCA Healthcare Company Profile
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also
- Five stocks we like better than HCA Healthcare
- How to buy stock: A step-by-step guide for beginners
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- The How And Why of Investing in Oil Stocks
- AbbVie Stock: A Perfect Dip for Investors to Buy
- P/E Ratio Calculation: How to Assess Stocks
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.